This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2021 Jan 14;384(2):154-164.

doi: 10.1056/NEJMra2028910.

Ewing's Sarcoma

Nicolò Riggi¹, Mario L Suvà¹, Ivan Stamenkovic¹

Affiliations

Affiliation

¹ From the Institute of Pathology, Faculty of Biology and Medicine, University of Lausanne and Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (N.R., I.S.); and the Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, and the Broad Institute of Harvard University and the Massachusetts Institute of Technology, Cambridge - both in Massachusetts (M.L.S.).

PMID: 33497548
DOI: 10.1056/NEJMra2028910

Review

Ewing's Sarcoma

Nicolò Riggi et al. N Engl J Med. 2021.

. 2021 Jan 14;384(2):154-164.

doi: 10.1056/NEJMra2028910.

Authors

Nicolò Riggi¹, Mario L Suvà¹, Ivan Stamenkovic¹

Affiliation

¹ From the Institute of Pathology, Faculty of Biology and Medicine, University of Lausanne and Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (N.R., I.S.); and the Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, and the Broad Institute of Harvard University and the Massachusetts Institute of Technology, Cambridge - both in Massachusetts (M.L.S.).

PMID: 33497548
DOI: 10.1056/NEJMra2028910

No abstract available

PubMed Disclaimer

Comment in

Ewing's Sarcoma.
Ludwig JA, Meyers PA, Dirksen U. Ludwig JA, et al. N Engl J Med. 2021 Apr 15;384(15):1476. doi: 10.1056/NEJMc2102423. N Engl J Med. 2021. PMID: 33852792 No abstract available.
Ewing's Sarcoma.
Blay JY, De Pinieux G, Gouin F. Blay JY, et al. N Engl J Med. 2021 Apr 15;384(15):1477. doi: 10.1056/NEJMc2102423. N Engl J Med. 2021. PMID: 33852793 No abstract available.

Similar articles

Promiscuous partnerships in Ewing's sarcoma.
Sankar S, Lessnick SL. Sankar S, et al. Cancer Genet. 2011 Jul;204(7):351-65. doi: 10.1016/j.cancergen.2011.07.008. Cancer Genet. 2011. PMID: 21872822 Free PMC article. Review.
Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C, Ren T, Yang K, Wang S, Bao X, Zhang F, Guo W. Ren C, et al. J Exp Clin Cancer Res. 2016 Mar 11;35:44. doi: 10.1186/s13046-016-0321-3. J Exp Clin Cancer Res. 2016. PMID: 26969300 Free PMC article.
Ewing's sarcoma: a miracle drug waiting to happen?
Longtin R. Longtin R. J Natl Cancer Inst. 2003 Nov 5;95(21):1574-6. doi: 10.1093/jnci/95.21.1574. J Natl Cancer Inst. 2003. PMID: 14600088 No abstract available.
R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
Huang HJ, Angelo LS, Rodon J, Sun M, Kuenkele KP, Parsons HA, Trent JC, Kurzrock R. Huang HJ, et al. PLoS One. 2011;6(10):e26060. doi: 10.1371/journal.pone.0026060. Epub 2011 Oct 11. PLoS One. 2011. PMID: 22022506 Free PMC article.
Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A, Toretsky JA. Uren A, et al. Future Oncol. 2005 Aug;1(4):521-8. doi: 10.2217/14796694.1.4.521. Future Oncol. 2005. PMID: 16556028 Review.

See all similar articles

Cited by

Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma.
Ringwalt EM, Currier MA, Glaspell AM, Chen CY, Cannon MV, Cam M, Gross AC, Gust M, Wang PY, Boon L, Biederman LE, Schwarz E, Rajappa P, Lee DA, Mardis ER, Carson WE, Roberts RD, Cripe TP. Ringwalt EM, et al. Mol Ther Oncol. 2024 Sep 26;32(4):200886. doi: 10.1016/j.omton.2024.200886. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39492947 Free PMC article.
STAG2 loss in Ewing sarcoma alters enhancer-promoter contacts dependent and independent of EWS::FLI1.
Giménez-Llorente D, Cuadrado A, Andreu MJ, Sanclemente-Alamán I, Solé-Ferran M, Rodríguez-Corsino M, Losada A. Giménez-Llorente D, et al. EMBO Rep. 2024 Nov 1. doi: 10.1038/s44319-024-00303-6. Online ahead of print. EMBO Rep. 2024. PMID: 39487368
Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling.
Dupuy M, Gueguinou M, Postec A, Brion R, Tesfaye R, Mullard M, Regnier L, Amiaud J, Hubsch C, Potier-Cartereau M, Chantôme A, Brounais-Le Royer B, Baud'huin M, Georges S, Lamoureux F, Ory B, Entz-Werlé N, Delattre O, Rédini F, Vandier C, Verrecchia F. Dupuy M, et al. Oncogene. 2024 Nov 1. doi: 10.1038/s41388-024-03199-7. Online ahead of print. Oncogene. 2024. PMID: 39487324
Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma.
Lin L, Zou J, Pei S, Huang W, Zhang Y, Zhao Z, Ding Y, Xiao C. Lin L, et al. Heliyon. 2024 Sep 11;10(19):e37726. doi: 10.1016/j.heliyon.2024.e37726. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39391510 Free PMC article.
Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma.
Wei E, Mitanoska A, O'Brien Q, Porter K, Molina M, Ahsan H, Jung U, Mills L, Kyba M, Bosnakovski D. Wei E, et al. Mol Cancer. 2024 Oct 5;23(1):222. doi: 10.1186/s12943-024-02115-7. Mol Cancer. 2024. PMID: 39367409 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information